Big Data Compliance Licensing Trials 
pharmaphorum
OCTOBER 16, 2020
In the age of artificial intelligence, no trial data should be going to waste. These might be licensed drugs that could hold potential for a patent extension, or drugs which failed efficacy trials for an intended indication. The repurposing of drugs is becoming more common, especially in the field of rare diseases.
Drug Discovery World
OCTOBER 12, 2022
Having these new data leads to greater understanding and enables precision medicine. . Why are digital biomarkers important in clinical trials? . Once collected, there are data analysis considerations surrounding the large amount of data and the connection to other data sources, such as EDC and eCOA data.
Expert insights. Personalized for you.
98 
Let's personalize your content